²Êºç¶à¶à¹ÙÍø

²úÆ·¿ÆÆÕ | ÄÔ´úл¸ÄÉÆÒ©¡ª¡ªßÁÀ­Î÷̹Ƭ

ʱ¼ä£º

2024-10-11

²úÆ·¿ÆÆÕ | ÄÔ´úл¸ÄÉÆÒ©¡ª¡ªßÁÀ­Î÷̹Ƭ

ßÁÀ­Î÷̹£¨Piracetam£©£¬£¬£¬ £¬£¬ÊÇÒ»ÖÖÄÜ×÷ÓÃÓÚÈÏÖª¹¦Äܶø²»»áÒýÆðÕò¾²»ò´Ì¼¤ÐÔ×÷ÓõÄÒ©Î£¬£¬ £¬£¬²¢¹ã·ºÓ¦ÓÃÓÚÖÐÊàÉñ¾­ÏµÍ³¼²²¡ÖÎÁÆÖС£¡£¡£¡£¡£¡£¡£¡£

»îÐԳɷݣºßÁÀ­Î÷̹

»¯Ñ§Ãû³Æ£º2-Ñõ´ú-1-ßÁ¿©Íé»ùÒÒõ£°·

·Ö×Óʽ£ºC6H10N2O2     

·Ö×ÓÁ¿£º142.16

ßÁÀ­Î÷̹µÄ

·¢Õ¹±³¾°

   20ÊÀ¼Í60Äê´ú£¬£¬£¬ £¬£¬GABA±»Ö¤ÊµÊÇÒ»ÖÖÖØÒªµÄÄÔÉñ¾­µÝÖÊÒÖÖƼÁ£¬£¬£¬ £¬£¬ÊÇÒ»ÖÖÓë˯ÃßÓйصÄÖØÒªµÄÒÖÖÆÐÔÉñ¾­µÝÖÊ£¬£¬£¬ £¬£¬ÕâÒýÆðÁËÈËÃǵĸ߶ÈÖØÊÓ£¬£¬£¬ £¬£¬ÓëGABAÏà¹ØµÄÒ©Àíѧ±»ÒýÈëҩѧ¹¤Òµ¡£¡£¡£¡£¡£¡£¡£¡£

 

1964Ä꣬£¬£¬ £¬£¬±ÈÀûʱÓÅʱ±È(UCB)ÖÆÒ©¹«Ë¾ºÏ³ÉÁ˦Ã-°±»ù¶¡Ëá(GABA)µÄ»·×´ÑÜÉúÎïßÁÀ­Î÷̹(1,Piracetam)£¬£¬£¬ £¬£¬Ä⿪·¢Æä³ÉΪÕò¾²Ò©£¬£¬£¬ £¬£¬È»¶ø¸ÃÒ©ËäÈ»ÓëGABAÏà¹Ø£¬£¬£¬ £¬£¬µ«ËüÈ´²»Ö±½ÓÓ°ÏìGABAÊÜÌ壬£¬£¬ £¬£¬Ò²Ã»ÓÐÓÕµ¼Ë¯ÃßµÄ×÷Ó㬣¬£¬ £¬£¬Ïà·´£¬£¬£¬ £¬£¬Giurgea²©Ê¿È´·¢ÏÖ¸ÃÒ©Äܹ»Ìá¸ßÈËÃǵÄÈÏÖªÄÜÁ¦¡£¡£¡£¡£¡£¡£¡£¡£

1971Ä꣬£¬£¬ £¬£¬¾­¹ýÉñ¾­Ò©Àíѧ¼Ò¡¢»¯Ñ§¼ÒGiurgea²©Ê¿¼á³Ö²»Ð¸µÄÑо¿£¬£¬£¬ £¬£¬µÚ1¸ö¾ßÓдÙÖÇ»îÐÔµÄÎ÷̹ÀàÒ©Î¡ªßÁÀ­Î÷̹ÕýʽÉÏÊС£¡£¡£¡£¡£¡£¡£¡£

 

1972Ä꣬£¬£¬ £¬£¬Giurgea²©Ê¿Ò²¸ù¾ÝßÁÀ­Î÷̹Ìá³öÁË¡°´ÙÖÇÒ©£¨nootrope£©¡±µÄ¸ÅÄî¡£¡£¡£¡£¡£¡£¡£¡£¡°nootrope¡±Ò»´Ê£¬£¬£¬ £¬£¬Ô´×ÔÏ£À°Ó¡ª noos´ú±í´ÏÃ÷µÄ£¬£¬£¬ £¬£¬tropein´ú±íÓÐÀûµÄ[1]¡£¡£¡£¡£¡£¡£¡£¡£

 

ÏÖÔÚ£¬£¬£¬ £¬£¬ßÁÀ­Î÷̹±»¹ã·ºÈÏΪÊÇÒ»ÖÖÄÔ´úл¸ÄÉÆÒ©£¬£¬£¬ £¬£¬Ö÷ÒªÓÃÓÚÖÎÁƼ±¡¢ÂýÐÔÄÔѪ¹Ü²¡¡¢ÄÔÍâÉË¡¢¸÷ÖÖÖж¾ÐÔÄÔ²¡µÈ¶àÖÖÔ­ÒòËùÖµļÇÒä¼õÍ˼°Çá¡¢ÖжÈÄÔ¹¦ÄÜÕÏ°­¡£¡£¡£¡£¡£¡£¡£¡£Ò²¿ÉÓÃÓÚ¶ùͯÖÇÄÜ·¢Óý³Ù»º¡£¡£¡£¡£¡£¡£¡£¡£

 

 

¶à°Ðµã

¸ÄÉÆÄÔ´úл

ÔÚÉñ¾­ÔªË®Æ½ÉÏ£¬£¬£¬ £¬£¬ßÁÀ­Î÷̹µ÷½ÚһϵÁеÝÖÊϵͳ£¨°üÀ¨µ¨¼îÄܺ͹Ȱ±ËáÄÜ£©µÄÉñ¾­´«µÝ£¬£¬£¬ £¬£¬¾ßÓÐÉñ¾­±£»£»£»£»£»¤ÐÔ£¬£¬£¬ £¬£¬²¢¸ÄÉÆÉñ¾­¿ÉËÜÐÔ£»£»£»£»£»ÔÚѪ¹ÜˮƽÉÏ£¬£¬£¬ £¬£¬ßÁÀ­Î÷̹¿ÉÒÔ¼õÉÙºìϸ°ûÓëѪ¹ÜÄÚƤµÄÕ³¸½£¬£¬£¬ £¬£¬·ÀֹѪ¹Ü¾·ÂΣ¬£¬£¬ £¬£¬´Ù½ø΢ѭ»·[2]¡£¡£¡£¡£¡£¡£¡£¡£

 

ßÁÀ­Î÷̹µÄ

ÁÙ´²Ó¦ÓÃ

ÈÏÖª¹¦ÄÜÕÏ°­

±ÈÀûʱµÄÑо¿ÈËÔ±¶Ô19Ïî˫ä¡¢°²Î¿¼Á¶ÔÕÕµÄÑо¿½øÐÐÁË·ÖÎö£¬£¬£¬ £¬£¬Ñо¿¶ÔÏóÊÇ»¼ÓгմôÖ¢»òÈÏÖªÕÏ°­µÄ»¼Õß¡£¡£¡£¡£¡£¡£¡£¡£ÕâÏîÜöÝÍ·ÖÎöµÄ½á¹ûÖ¤Ã÷ÁËʹÓÃßÁÀ­Î÷̹ºÍʹÓð²Î¿¼ÁµÄÈËÖ®¼ä´æÔÚ²îÒ죬£¬£¬ £¬£¬³¬¹ý60%µÄ½ÓÊÜßÁÀ­Î÷̹ÖÎÁƵĻ¼ÕßÔÚCGICÆÀ·ÖÖÐÓиÄÉÆ£¬£¬£¬ £¬£¬Ò²¾ÍÊÇ˵½á¹ûÊÇÕýÏòµÄ£¬£¬£¬ £¬£¬±íÃ÷ßÁÀ­Î÷̹ÔÚ¸ÄÉÆÈÏÖªÕÏ°­·½ÃæµÄÒæ´¦£¬£¬£¬ £¬£¬ÎªÖ¤ÊµßÁÀ­Î÷̹ÓÃÓÚ²»Í¬ÈÏÖªÕÏ°­ÈËȺµÄÓÐЧÐÔÌṩÁËÖ¤¾Ý[3]¡£¡£¡£¡£¡£¡£¡£¡£

Á­µ¶ÐÍϸ°ûƶѪ²¡

Á­µ¶ÐÍϸ°ûƶѪ²¡ÊÇÒ»ÖÖÓÉÒì³£»£»£»£»£»òÁ­×´Ñªºìµ°°×ÒýÆðµÄÒÅ´«ÐÔ¼²²¡£¬£¬£¬ £¬£¬ÕâЩ»¼Õߵĺìϸ°û¸üÈÝÒ×Õ³¸½ÔÚÄÚƤ±ÚÉÏ¡£¡£¡£¡£¡£¡£¡£¡£ÕâÖÖºìϸ°ûÕ³¸½ÇãÏòÓÚ×èÈûëϸѪ¹ÜѪÁ÷£¬£¬£¬ £¬£¬µ¼Ö¾ֲ¿×éÖ¯ËðÉ˺ÍÌÛÍ´£¬£¬£¬ £¬£¬³ÆΪÁ­×´Ï¸°ûΣÏ󡣡£¡£¡£¡£¡£¡£¡£ßÁÀ­Î÷̹¶Ôºìϸ°û²úÉúÁ˶àÖÖÓ°Ï죬£¬£¬ £¬£¬Ê¹Æä³ÉΪÖÎÁÆÕâÖÖ¼²²¡µÄDZÔÚºòÑ¡Ò©Îï¡£¡£¡£¡£¡£¡£¡£¡£Ò»·Ý·¢±íÔÚ¡¶ÁøÒ¶µ¶¡·ÉϵÄÑо¿ÏÔʾ£¬£¬£¬ £¬£¬ßÁÀ­Î÷̹ÖÎÁÆÁ­µ¶ÐÍϸ°ûƶѪ²¡ÓÐЧ£¬£¬£¬ £¬£¬ÇÒÎÞ¸±×÷ÓÃ[4]¡£¡£¡£¡£¡£¡£¡£¡£

³ý´ËÖ®Í⣬£¬£¬ £¬£¬ßÁÀ­Î÷̹ÔÚÖÎÁÆÀÏÄê³Õ´ô¡¢Ñ£ÔΡ¢Öз硢¶ùͯÔĶÁÕÏ°­µÈ¶¼ÏÔʾ³öÓÐЧÐÔ¡£¡£¡£¡£¡£¡£¡£¡£

 

×ܽá

ßÁÀ­Î÷̹ÊÇÒ»ÖÖ¸ÄÉÆÄÔ´úлÀàÒ©Î£¬£¬ £¬£¬ÆäÒ©Àí»úÖÆÈÔÔÚ²»¶Ï̽Ë÷ÖУ¬£¬£¬ £¬£¬Ä¿Ç°µÄѭ֤ҽѧ֤¾ÝÒѾ­±íÃ÷Æä¾ßÓиÄÉÆÉñ¾­Ôª¹¦ÄÜ¡¢¸ÄÉÆ΢ѭ»·µÄ×÷Ó㬣¬£¬ £¬£¬ßÁÀ­Î÷̹ÉÏÊÐÖÁ½ñÒÑ50ÓàÄ꣬£¬£¬ £¬£¬Òѹ㷺ӦÓÃÓÚÈÏÖª¹¦ÄÜÕÏ°­ºÍÄÔѪ¹Ü¼²²¡µÈµÄÁÙ´²ÖÎÁÆ£¬£¬£¬ £¬£¬ÇÒ¾ßÓнϺÃÖÎÁÆЧ¹û¡£¡£¡£¡£¡£¡£¡£¡£

 

²Î¿¼ÎÄÏ×

[1] ËÎÑÞÁá,Ëﻶ,Àî°ØÄÈ.Î÷̹ÀàÒ©ÎïÑо¿½øÕ¹[J].ÖйúÒ©Òµ,2015,24(01):4-7.

[2] Winblad B. Piracetam: a review of pharmacological properties and clinical uses. CNS Drug Rev. 2005 Summer;11(2):169-82.

[3] Waegemans T, Wilsher CR, Danniau A, Ferris SH, Kurz A, Winblad B. Clinical efficacy of piracetam in cognitive impairment: A meta-analysis. Dement Geriatr Cogn Disord 2002;13:217¨C224.

[4] de Araujo JT, Nero GS. Piracetam and acetamide in sickle-cell disease. Lancet. 1977 Aug 20;2(8034):411. PMID: 70630.

 

 

Ìرð˵Ã÷£º±¾ÎÄÄÚÈݲ¿·ÖÀ´Ô´ÒÔÉϲο¼ÎÄÏ×£¬£¬£¬ £¬£¬½ö×öÐÅÏ¢ÕûºÏ·ÖÏí£¬£¬£¬ £¬£¬²»´ú±íÈκÎÓÃÒ©½¨Ò飬£¬£¬ £¬£¬ÈçÓÐÇÖȨ¡¢ÐÅÏ¢ÓÐÎó»òÆäËûÒìÒ飬£¬£¬ £¬£¬ÇëÁªÏµ²Êºç¶à¶à¹ÙÍø½øÐÐɾ³ý£¡

 

¡¾ÍøÕ¾µØͼ¡¿¡¾sitemap¡¿